BAX
Baxter International Inc. · Healthcare
No insider bought or sold Baxter International Inc. in the last 12 months
BAX over the last year
BAX after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Congress
Members reported 76 trades in BAX since 2023.
Every filing
91 insider filings since 2016, newest first
Jeanne K Mason · EVP and CHRO
Albert P L Stroucken · Director
Jacqueline Kunzler · SVP and Chief Quality Officer
Jeanne K Mason · SVP and HR
Albert P L Stroucken · Director
Peter S Hellman · Director
John D Forsyth · Director
John D Forsyth · Director
Brian Stevens · SVP, CAO, Controller
Jeanne K Mason · SVP and HR
Thomas F Chen · Director
John D Forsyth · Director
Sean Martin · SVP and General Counsel
Sean Martin · SVP and General Counsel
Andrew Frye · SVP, Pres, APAC
Albert P L Stroucken · Director
Peter S Hellman · Director
Sean Martin · SVP and General Counsel
John D Forsyth · Director
James R Gavin III · Director
Giuseppe Accogli · SVP, Pres, Americas
John D Forsyth · Director
Cristiano Franzi · SVP, Pres, EMEA
Andrew Frye · SVP, Pres, APAC
Jeanne K Mason · SVP and HR
Albert P L Stroucken · Director
Peter S Hellman · Director
John D Forsyth · Director
John D Forsyth · Director
Andrew Frye · SVP, Pres, APAC
Jacqueline Kunzler · SVP and Chief Quality Officer
James R Gavin III · Director
Jacqueline Kunzler · SVP and Chief Quality Officer
John D Forsyth · Director
Third Point LLC · Insider
Thomas T Stallkamp · Director
Albert P L Stroucken · Director
Thomas T Stallkamp · Director
Peter S Hellman · Director
Scott Pleau · SVP, Operations
Giuseppe Accogli · SVP, Pres, Global Bus.
John D Forsyth · Director
Thomas T Stallkamp · Director
Thomas T Stallkamp · Director
Jeanne K Mason · SVP and HR
Thomas T Stallkamp · Director
Carole J Shapazian · Director
John D Forsyth · Director
Carole J Shapazian · Director
Third Point LLC · Insider
About Baxter International Inc.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.